Breakthrough AI-driven drug discovery

Better tech for better patient outcomes

Entos pioneered quantum AI, revolutionizing drug discovery by deepening the exploration of chemical space

We illuminate novel chemical matter to unlock better development candidates.
‍
We drive to clinic faster through our high-throughput discovery platform.

Our pipeline Our technology

Accelerated molecular design

Powerful simulations

OrbNet uses quantum features to
produce 1000x acceleration in
quantum mechanics calculations

Data-efficient ML

Proprietary quantum features lead to
100x reduction in data requirements
for ML property prediction

Automated chemistry

Automated synthesis and experiment
guided by ML, driving continuous
model improvement

Trusted by

Our work

Entos in the news

Press Release

Apr 7, 2023

Entos Head of Business Development Mary Anderson among top 25 healthcare technology leaders of San Diego for 2022

Chao Zhang joins Entos as Chief Scientific Officer

Chao's recruitment heralds the transition of Entos from a discovery-stage to a clinical-stage AI-driven biotech

Entos in Forbes AI50

Entos selected by Forbes Magazine for 2022 list of groundbreaking artificial intelligence companies

Learn More







Publication

Apr 18, 2023

Entos Presents Preclinical Data on its First Clinical Candidate

Entos Recruits Tom Daniel, M.D., to its Scientific Advisory Board

Tom Miller Presents at the NVIDIA Spring GTC23 Event

Generative AI startups to watch in Healthcare Life Sciences

Entos Recruits William Rastetter to Board and Announces Clinical Advisory Board

Entos Presents Latest AI-Driven Drug Discovery Advances at NeurIPS 2022

Entos Head of Business Development Mary Anderson among top 25 healthcare technology leaders of San Diego for 2022

Learn More







Publication

Apr 18, 2023

Entos Presents Preclinical Data on its First Clinical Candidate

Entos Recruits Tom Daniel, M.D., to its Scientific Advisory Board

Tom Miller Presents at the NVIDIA Spring GTC23 Event

Generative AI startups to watch in Healthcare Life Sciences

Entos Recruits William Rastetter to Board and Announces Clinical Advisory Board

Entos Presents Latest AI-Driven Drug Discovery Advances at NeurIPS 2022

Entos Head of Business Development Mary Anderson among top 25 healthcare technology leaders of San Diego for 2022

Learn More







Browse all

Our Mission

Entos is revolutionizing drug discovery through technology

Our team collaborates to build next-generation technologies

Our goal is to empower each other to do our best work

Our vision is faster, safer therapeutics discovery

Join us

Jeanne Grover

Director, Finance & Operations

Shane Yost

Applications Scientist

Elizabeth Ter Sahakyan

Lead Product Dev Engineer

Wallace Derricotte

Research Scientist

Feizhi Ding

Senior Software Engineer

Join us as we change the game in drug discovery

We are rapidly expanding our team and are hiring experts in medicinal chemistry, discovery biology, automation, and machine learning.

View Openings

Entos presents preclinical data on its first clinical candidate

Entos' presentation at the annual meeting of the American Association for Cancer Research (AACR) highlights the preclinical data for its first clinical candidate, ENT-H1, generated using its proprietary AI-driven drug discovery platform.

Breakthrough AI-driven drug discovery

Entos accelerates molecular discovery

Entos pioneered quantum AI, revolutionizing drug discovery by deepening the exploration of chemical space

Accelerated molecular design

Powerful simulations

Data-efficient ML

Automated chemistry

Entos in the news

Entos Recruits Tom Daniel, M.D., to its Scientific Advisory Board

Entos Recruits William Rastetter to Board and Announces Clinical Advisory Board

Entos Presents Latest AI-Driven Drug Discovery Advances at NeurIPS 2022

Entos Head of Business Development Mary Anderson among top 25 healthcare technology leaders of San Diego for 2022

Chao Zhang joins Entos as Chief Scientific Officer

Entos in Forbes AI50

Entos Presents Preclinical Data on its First Clinical Candidate

Entos Recruits Tom Daniel, M.D., to its Scientific Advisory Board

Tom Miller Presents at the NVIDIA Spring GTC23 Event

Entos Recruits William Rastetter to Board and Announces Clinical Advisory Board

Entos Presents Latest AI-Driven Drug Discovery Advances at NeurIPS 2022

Entos Head of Business Development Mary Anderson among top 25 healthcare technology leaders of San Diego for 2022

Entos Presents Preclinical Data on its First Clinical Candidate

Entos Recruits Tom Daniel, M.D., to its Scientific Advisory Board

Tom Miller Presents at the NVIDIA Spring GTC23 Event

Entos Recruits William Rastetter to Board and Announces Clinical Advisory Board

Entos Presents Latest AI-Driven Drug Discovery Advances at NeurIPS 2022

Entos Head of Business Development Mary Anderson among top 25 healthcare technology leaders of San Diego for 2022

Entos is revolutionizing drug discovery through technology

Join us as we change the game in drug discovery

Entos presents preclinical data on its first clinical candidate